Dimensional Fund Advisors’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Dimensional Fund Advisors’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-21,197	Closed	-$390K	–	3439
2020 Q4	$390K	Hold	21,197	–	–	﹤0.01%	3136
2020 Q3	$389K	Hold	21,197	–	–	﹤0.01%	3111
2020 Q2	$317K	Hold	21,197	–	–	﹤0.01%	3153
2020 Q1	$335K	Hold	21,197	–	–	﹤0.01%	3128
2019 Q4	$344K	Hold	21,197	–	–	﹤0.01%	3190
2019 Q3	$315K	Hold	21,197	–	–	﹤0.01%	3214
2019 Q2	$350K	Hold	21,197	–	–	﹤0.01%	3246
2019 Q1	$367K	Hold	21,197	–	–	﹤0.01%	3216
2018 Q4	$374K	Hold	21,197	–	–	﹤0.01%	3189
2018 Q3	$385K	Hold	21,197	–	–	﹤0.01%	3219
2018 Q2	$414K	Hold	21,197	–	–	﹤0.01%	3148
2018 Q1	$4K	Hold	21,197	–	–	﹤0.01%	3344
2017 Q4	$2K	Buy	21,197 +4,912	+30%	+$51.3K	﹤0.01%	3323
2017 Q3	$2K	Buy	+16,285	New	+$154K	﹤0.01%	3335

Dimensional Fund Advisors's CBMG Position: Q1 2021 in Review

Dimensional Fund Advisors sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 21,197 shares — an estimated $390K sold.

Dimensional Fund Advisors first reported a position in CBMG in Q3 2017 and held it in 14 quarters. The position peaked at $414K in Q2 2018. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Dimensional Fund Advisors reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Dimensional Fund Advisors sold 21,197 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $390K.
Dimensional Fund Advisors first reported a position in Cellular Biomedicine Group, Inc. in Q3 2017 and held it in 14 quarters.
Dimensional Fund Advisors's Cellular Biomedicine Group, Inc. position peaked at $414K in Q2 2018.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Dimensional Fund Advisors's 13F filing for Q1 2021, filed 14 May 2021.